Cholera pp 129-154 | Cite as

The Epidemiology of Cholera

  • Roger I. Glass
  • Robert E. Black
Part of the Current Topics in Infectious Disease book series (CTID)

Abstract

Since the first pandemic of cholera in 1817 spread through the Middle East to Europe, cholera has been among the most feared of the classic epidemic diseases.1 Cholera was highly virulent, decimating entire communities within weeks of its introduction. The disease had a high case-fatality ratio that approached 50% in some areas and spread relentlessly in worldwide pandemics from endemic foci in Asia to the Middle East, Europe, East Africa, and the Americas. While cholera epidemics have been extensively described and studied, epidemiologic understanding of the transmission of V. cholerae 01 is still too inadequate to permit effective control measures that would contain the disease and prevent its emergence and spread.2 Proper and timely rehydration therapy can reduce mortality to less than 1%, and antibiotic treatment can decrease shedding of vibrios, but neither of these treatment measures has significantly altered the spread of disease.

Keywords

Phage Type Family Contact Endemic Setting Cholera Outbreak Cholera Vibrio 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Pollitizer R: Cholera. Monograph No. 43, Geneva, World Health Organization, 1959.Google Scholar
  2. 2.
    World Health Organization: Guidelines for Control of Cholera. Programme for Control of Diarrhoeal Diseases. WHO CDD SER 80.4 Rev.2, Geneva, 1991.Google Scholar
  3. 3.
    Snow J: Snow on Cholera. Hafner Publications Co., New York, 1962.Google Scholar
  4. 4.
    Koch R: An address on cholera and its bacillus. Br Med J 2: 403–407, 453.-459, 1884.PubMedGoogle Scholar
  5. 5.
    Feachem RG: Environmental aspects of cholera epidemiology. III. Transmission and control. Trop Dis Bull 79: 1–47, 1982.PubMedGoogle Scholar
  6. 6.
    Borneside GH: Jaime Ferran and preventive inoculation against cholera. Bull Hist Med 55: 516–532, 1981.Google Scholar
  7. 7.
    Feachem RG: Environmental aspects of cholera epidemiology. II. Occurrence and survival of Vibrio cholerae in the environment. Trop Dis Bull 78: 865–880, 1981.PubMedGoogle Scholar
  8. 8.
    Colwell RR, Seidler RJ, Kaper J, Joseph SW, et al: Occurrence of Vibrio cholerae serotype 01 in Maryland and Louisiana estuaries. Appl Environ Microbiol 42: 555–558, 1981.Google Scholar
  9. 9.
    Blake PA, Allegra DT, Snyder JD, et al: Cholera-A possible endemic focus in the United States. N Engl J Med 302: 305–309, 1980.PubMedGoogle Scholar
  10. 10.
    Baine WB, Zampieri A, Mazzotti M, et al: Epidemiology of cholera in Italy in 1973. Lancet ii: 1370–1376, 1974.Google Scholar
  11. 11.
    Salamaso S, Greco D, Bonfiglio B, et al: Recurrence of pelecypod-associated cholera in Sardinia. Lancet ii: 1124–1128, 1980.Google Scholar
  12. 12.
    Joseph PR, Tamayo JF, Mosley WH, et al: Studies of cholera El Tor in the Philippines. 2. A retrospective investigation of an explosive outbreak in Bacalod City and Talisay, November 1961. Bull WHO 33: 637–643, 1965.PubMedGoogle Scholar
  13. 13.
    Blake PA, Rosenberg ML, Bandeira Costa J, et al: Cholera in Portugal, 1974. I. Modes of transmission. Am J Epidemiol 105: 337–343, 1977.PubMedGoogle Scholar
  14. 14.
    Pavia AT, Smith JD, Campbell JF, et al: Cholera from raw oysters shipped interstate? JAMA 258: 2374, 1987.PubMedGoogle Scholar
  15. 15.
    Goodgame RW, Greenough WB: Cholera in Africa: A message for the west. Ann Intern Med 82: 101–106, 1975.PubMedGoogle Scholar
  16. 16.
    Stock RF: Cholera in Africa: Diffusion of the Disease 1970–1975 with Particular Emphasis on West Africa. African Environmental Special Report 3. London, International African Institute, 1976.Google Scholar
  17. 17.
    Sitas F: Some observations on a cholera outbreak at the Umvoti Mission Reserve, Natal. S Afr Med J 70: 215–218, 1986.PubMedGoogle Scholar
  18. 18.
    Mhalu FS, Mtango FDE, Msengi AE: Hospital outbreaks of cholera transmitted through close person-to-person contact. Lancet ii: 82–84, 1984.Google Scholar
  19. 19.
    Felize H: Le development de l’epidemic de cholera en Afrique de l’Ouest. Bull Soc Pathol Exot 64: 561–586, 1971.Google Scholar
  20. 20.
    Cliff JL, Zinkin P, Martell A: A hospital outbreak of cholera in Maputo, Mozambique. Trans R Soc Trop Med Hyg 80: 473–476, 1986.PubMedGoogle Scholar
  21. 21.
    Barua D: The global epidemiology of cholera in recent years. Proc Soc Med 65: 423–432, 1972.Google Scholar
  22. 22.
    Kamal AM: The seventh pandemic of cholera. in Barua D, Burrows W (eds.): Cholera Philadelphia, W.B. Saunders Co., 1974, pp 1–14.Google Scholar
  23. 23.
    Weissman JB, DeWitt WE, Thompson J, et al: A case of cholera in Texas, 1973. Am J Epidemiol 100: 487–498, 1974.PubMedGoogle Scholar
  24. 24.
    Johnston JM, Martin DL, Perdue J, et al. Cholera on a Gulf Coast oil rig. New Engl J Med 309: 523–526, 1983.PubMedGoogle Scholar
  25. 25.
    Blake PA, Wachsmuth K, Davis BR: Toxigenic Vibrio cholerae 01 strains from Mexico identical to United States isolates? Lancet ii: 912, 1983.Google Scholar
  26. 26.
    World Health Organization: Weekly Epidemiol Rep 1991: 55-70.Google Scholar
  27. 27.
    Huq MI, Glass RI, Stoll BJ: Epidemiology of cholera. N Engt J Med 303: 643–644, 1980.Google Scholar
  28. 28.
    Shahid NS, Samadi AR, Khan MU, et al: Classical vs. El Tor cholera. A prospective family study of a concurrent outbreak? J Diarrhoeal Dis Res 2: 73, 1984.PubMedGoogle Scholar
  29. 29.
    Institute of Medicine: New Vaccine Development: Establishing Priorities. Volume II, Diseases of Importance in Developing Countries. Washington, DC, National Academy Press, 1986.Google Scholar
  30. 30.
    Glass RI, Becker S, Huq MI, et al: Endemic cholera in rural Bangladesh. Am J Epidemiol 116: 959–970, 1982.PubMedGoogle Scholar
  31. 31.
    Black RE: The epidemiology of cholera and enterotoxigenic Escherichia coli diarrheal disease, in Holmgren J, Lindberg A, Mollby R (eds.): Development of Vaccines and Drugs against Diarrhea. Eleventh Nobel Conference. Stockholm 1985. Lund, Sweden, Studentliteratur, 1986, pp 23–32.Google Scholar
  32. 32.
    Mahalanabis D, Brayton J, Mondai A, and Pierce NF: The use of Ringer’s lactate in the treatment of children with cholera and non-cholera diarrhea. Bull WHO 46: 311–319, 1972.PubMedGoogle Scholar
  33. 33.
    Baqui AH, Yunus M, Zaman K: Community-operated treatment centres prevented many cholera deaths. J Diarrhoeal Dis Res 2: 92–98, 1984.PubMedGoogle Scholar
  34. 34.
    Mandara MP, Mhalu FS: Cholera control in an inaccessible district in Tanzania: Importance of temporary rural centers. Med J Zambia 15: 10–13, 1980.PubMedGoogle Scholar
  35. 35.
    Barua D: Laboratory diagnosis of cholera, in Barua D, Burrows W (eds.): Cholera. Philadelphia, WB Saun-ders, 1974, pp 85–128.Google Scholar
  36. 36.
    Mukerjee S, Takeya K: Vibrio-phages and vibriocins, in Barua D, Burrows W (eds.): Cholera. Philadelphia, WB Saunders, 1974, pp 61–83.Google Scholar
  37. 37.
    Takeya K, Shimodori S, Gomez CZ: Kappa-type phage detection as a method for the tracing of cholera El Tor carriers. Bull WHO 37: 806–810, 1967.PubMedGoogle Scholar
  38. 38.
    Lee JH, Furniss AL: Discussion 1: the phage-typing of Vibrio cholerae serovar 01, in Holme T, Holmgren J, Merson MH, Mollby R, (eds.): Acute Enteric Infections in Children. New Prospects for Treatment and Prevention. Amsterdam, Elsevier/North Holland, 1981, pp 119-122.Google Scholar
  39. 39.
    Mhalu FS, Mmari PW, Ijumga J: Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania. Lancet i: 345–347, 1979.Google Scholar
  40. 40.
    Glass RI, Huq MI, Lee JV, et al: Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup 01, biotype El Tor: evidence for a point-source outbreak in Bangladesh. J Infect Dis 147: 204–209, 1983.PubMedGoogle Scholar
  41. 41.
    Kaper JB, Bradford HB, Roberts NC, Falkow S: Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J Clin Microbiol 16: 129–134, 1982.PubMedGoogle Scholar
  42. 42.
    Shandera WX, Hafkin B, Martin DL, et al: Persistence of cholera in the United States. Am J Trop Med Hyg 32: 812–817, 1983.PubMedGoogle Scholar
  43. 43.
    Glass RI, Lee JV, Huq MI, et al: Phage types of Vibrio cholerae 01 biotype El Tor isolated from patients and family contacts in Bangladesh: epidemiologic implications. J Infect Dis 148: 998–1004, 1983.PubMedGoogle Scholar
  44. 44.
    Finkelstein RA: Vibriocidal antibody inhibition (VA1) analysis: a technique for the identification of the predominant vibriocidal antibodies in serum and for the detection and identification of Vibrio cholerae antigens. J Immunol 89: 264–271, 1962.Google Scholar
  45. 45.
    Svennerholm A-M, Holmgren J, Black R, et al: Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis 47: 514–522, 1983.Google Scholar
  46. 46.
    Svennerholm A-M, Wikstrom M, Lindblad M, and Holmgren J: Monoclonal antibodies to Escherichia coli heat labile enterotoxins: neutralizing activity and differentiation of human and porcine LTs and cholera toxin. Med Biol 64: 23–30, 1986.PubMedGoogle Scholar
  47. 47.
    Levine MM, Nalin DR, Craig JP, et al: Immunity of cholera in man: relative role of antibacterial versus toxic immunity. Trans R Soc Trop Med Hyg 73: 3–9, 1979.PubMedGoogle Scholar
  48. 48.
    Sears SD, Richardson K, Young C, et al: Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect Immun 44: 439–444, 1984.PubMedGoogle Scholar
  49. 49.
    Mosley, WH: The role of immunity in cholera: A review of epidemiological and serological studies. Texas Rev of Biol Med 27(suppl. 1):227–241, 1969.Google Scholar
  50. 50.
    Glass RI, Svennerholm AM, Khan MR, et al: Seroepidemiological studies of El Tor cholera in Bangladesh: implications for vaccine development and field trials. J Infect Dis 151: 236-242.Google Scholar
  51. 51.
    Mosley WH: Epidemiology of cholera, in Principles and Practice of Cholera Control. Public Health Papers No. 40. Geneva, World Health Organization, 1970, pp 23-27.Google Scholar
  52. 52.
    Harris JR, Holmberg SD, Parker RDR, et al: Impact of epidemic cholera in a previously uninfected island population: Evaluation of a new seroepidemiologic method. Am J Epidemiol 123: 424–430, 1986.PubMedGoogle Scholar
  53. 53.
    Levine MM, Young CR, Hughes TP, et al: Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am J Epidemiol 114: 348–354, 1981.PubMedGoogle Scholar
  54. 54.
    Snyder JD, Allegra DT, Levine MM, et al: Serologic studies of naturally acquired infection with Vibrio cholerae serogroup 01 in the United States. J Infect Dis 143: 182–187, 1981.PubMedGoogle Scholar
  55. 55.
    Clements ML, Levine MM, Young CR, et al: Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis 145: 465–473, 1982.PubMedGoogle Scholar
  56. 56.
    Dizon JJ, Fukumi H, Barua D, et al: Studies on cholera carriers. Bull WHO 37: 737–743, 1967.PubMedGoogle Scholar
  57. 57.
    Woodward WE, Moseley WH: The spectrum of cholera in rural Bangladesh. II. Comparison of El Tor Ogawa and classical Inaba infection. Am J Epidemiol 96: 342–351, 1971.Google Scholar
  58. 58.
    Stanton BF, Clemens JD: Soiled saris: a vector of disease transmission. Trans R Soc Trop Med Hyg 80: 485–488, 1986.PubMedGoogle Scholar
  59. 59.
    Glass RI, Greenough WB, Holmgren J, Khan MR: The use of family studies for prospective epidemiologic investigations of cholera, in Kuwahara S, Pierce NF, (eds.): Advances in Research on Cholera and Related Diarrheas. Tokyo, KTK Scientific Publishers, 1986, pp 25–33.Google Scholar
  60. 60.
    McCormack WM, Chowdhury AM, Gahanger N, et al: Tetracycline prophylaxis in families of cholera patients. Bull WHO 38: 787–797, 1968.PubMedGoogle Scholar
  61. 61.
    Deb BC, Sircar BK, Sengupta PG, et al: Studies on interventions to prevent El Tor cholera transmission in urban slums. Bull WHO 64: 127-131.Google Scholar
  62. 62.
    Barrett TJ, Blake PA, Morris GK, et al: Use of Moore swabs for isolating Vibrio cholerae from sewage. J Clin Microbiol 11: 385–388, 1980.PubMedGoogle Scholar
  63. 63.
    Spira WM, Ahmed QS: Gauze filtration and enrichment procedures for recovery of Vibrio cholerae from contaminated waters. Appl Environ Microbiol 42: 731–733, 1981.Google Scholar
  64. 64.
    Miller CJ, Feachem RG, Drasar BS: Cholera epidemiology in developed and developing countries: New thoughts on transmission, seasonality and control. Lancet i: 261–263, 1985.Google Scholar
  65. 65.
    Dizon JJ: Cholera carriers, in Barua D, Burrows W (eds.): Cholera. Philadelphia, WB Saunders, 1974, pp 367–380.Google Scholar
  66. 66.
    McCormick WM, Isam MS, Fahimuddin M, et al: A community study of inapparent cholera infections. Am J Epidemiol 89: 658–664, 1969.Google Scholar
  67. 67.
    Pierce NF, Banwell JG, Sack RB, et al: Convalescent carriers of Vibrio cholerae. Detection and detailed investigation. Ann Intern Med 72: 357–364, 1970.PubMedGoogle Scholar
  68. 68.
    Azurin JC, Koban K, Barua D, et al: A long-term carrier of cholera: Cholera Dolores. Bull WHO 37: 745–749, 1967.PubMedGoogle Scholar
  69. 69.
    Miller CJ, Drasar BS, Feachem RG: Cholera and estuarine salinity in Calcutta and London. Lancet i: 1216–1218, 1982.Google Scholar
  70. 70.
    Levine MM, Black RE, Clements ML, et al: Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect Immun 43: 515–522, 1984.PubMedGoogle Scholar
  71. 71.
    Nalin DR, Levine RJ, Levine MM, et al: Cholera, non-vibrio cholera, and stomach acid. Lancet ii: 856–859, 1978.Google Scholar
  72. 72.
    Cash RA, Music SI, Libonati JP, et al: Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologie responses to a known inoculum. J Infect Dis 129: 45–52, 1974.PubMedGoogle Scholar
  73. 73.
    Levine MM, Black RE, Clements ML, et al: Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: A review, in Holme T, Holmgren J. Merson MH, Mollby R (eds): Acute Enteric Infections in Children, New Prospects for Treatment and Prevention. Elsevier/North-Holland Biomedical Press, 1981, pp 443-459.Google Scholar
  74. 74.
    Abdou S: Susceptibility to cholera. Lancet i:903, 1948.Google Scholar
  75. 75.
    Gitelson S: Gastrectomy, achlorhydria and cholera. Israel J Med Sci 7: 663–667, 1971.PubMedGoogle Scholar
  76. 76.
    Sack GH, Pierce NF, Hennessey KN, et al: Gastric acidity in cholera and noncholera diarrhoea. Bull WHO 47: 31–36, 1972.PubMedGoogle Scholar
  77. 77.
    Schiraldi O, Benvestito V, Di Bari C, et al: Gastric abnormalities in cholera: epidemiological and clinical considerations. Bull WHO 51: 349–352, 1974.PubMedGoogle Scholar
  78. 78.
    Thomason H, Burke V, Gracey M: Impaired gastric function in experimental malnutrition. Am J Clin Nutr 34: 1278–1280, 1981.PubMedGoogle Scholar
  79. 79.
    MacDonald WC, Rubin CE: Cancer, benign tumors, gastritis, and other gastric diseases, in Petersdorf RG, Adams RD, Braunwald E, et al (eds): Harrisons Principles of Internal Medicine, 10th Edition. New York, McGraw-Hill Book Co., 1983, p 1717.Google Scholar
  80. 80.
    Ruddell WSJ, Losowsky MS: Severe diarrhoea due to small intestinal colonisation during cimetidine treatment? Br Med J 281: 273, 1980.PubMedGoogle Scholar
  81. 81.
    Nalin DR, Levine MM, Rhead J, et al: Cannabis, hypochlorhydria, and cholera. Lancet ii: 859–861, 1978.Google Scholar
  82. 82.
    Bart KJ, Huq Z, Khan M, et al: Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis 121:S17–S24, 1970.Google Scholar
  83. 83.
    Spira WM, Khan MU, Saeed YA, et al: Microbiological surveillance of intra-neighbourhood El Tor cholera transmission in rural Bangladesh. Bull WHO 58: 731–740, 1980.PubMedGoogle Scholar
  84. 84.
    Pollitzer R: Cholera. Geneva, World Health Organization, 1959, pp 820–857.Google Scholar
  85. 85.
    Pollitzer R: Cholera. Geneva, World Health Organization, 1959, pp 51–56.Google Scholar
  86. 86.
    Webber RH, Mwakalukwa J: The epidemiology of cholera in South-West Tanzania. E Afr Med J 60: 848–856, 1983.Google Scholar
  87. 87.
    Khan M, Mosley WH: The role of boatman in the transmission of cholera. E Pak Med J 11: 61–65, 1967.Google Scholar
  88. 88.
    Briscoe J, Ahmed S, Chakraborty M: Domestic water use in a village in Bangladesh, I. A methodology and a preliminary analysis of use patterns during the “cholera season.” Prog Wat Tech 11: 131–141, 1978.Google Scholar
  89. 89.
    Hughes JM, Boyce JM, Levine RJ, et al: Epidemiology of El Tor cholera in rural Bangladesh: importance of surface water in transmission. Bull WHO 60: 395–404, 1982.PubMedGoogle Scholar
  90. 90.
    Sommer A, Woodward WE: The influence of protected water supplies on the spread of classical/inaba and El Tor/Ogawa cholera in Rural East Bengal. Lancet ii: 985–987, 1972.Google Scholar
  91. 91.
    Levine RJ, Khan MR, D’Souza S, et al: Failure of sanitary wells to protect against cholera and other diarrhoeas in Bangladesh. Lancet ii: 86–89, 1976.Google Scholar
  92. 92.
    Briscoe J: The role of water supply in improving health in poor countries (with special reference to Bangladesh). Am J Clin Nutr 31: 2100–2113, 1978.PubMedGoogle Scholar
  93. 93.
    Khan M, Mosley WH, Chakraborty J, et al: The relationship of cholera to water source and use in rural Bangladesh. Int J Epidemiol 10: 23–25, 1981.PubMedGoogle Scholar
  94. 94.
    Briscoe J: Intervention studies and the definition of dominant transmission routes. Am J Epidemiol 120: 449–455, 1984.PubMedGoogle Scholar
  95. 95.
    Deb BC, Sircar BK, Sengupta PG, et al: Intra-familial transmission of Vibrio cholerae biotype El Tor in Calcutta slums. Ind J Med Res 76: 814–819, 1982.Google Scholar
  96. 96.
    Azurin JC, Alvero M: Field evaluation of environmental sanitation measures against cholera. Bull WHO 51: 19–26, 1974.PubMedGoogle Scholar
  97. 97.
    Rogers RC, Cuffe RGCJ, Cossins YM, et al: The Queensland cholera incident of 1977. 2. The epidemiological investigation. Bull WHO 58: 665–669, 1980.PubMedGoogle Scholar
  98. 98.
    Glass RI, Alim ARMA, Eusof A, et al: Cholera in Indonesia: Epidemiologic studies of transmission in Aceh Province. Am J Trop Med Hyg 33: 933–939, 1984.PubMedGoogle Scholar
  99. 99.
    Blake PA, Rosenberg ML, Florencia J, et al: Cholera in Portugal, 1974. II. Transmission by bottled mineral water. Am J Epidemiol 105: 344–348, 1977.PubMedGoogle Scholar
  100. 100.
    Pollitzer R: Cholera. Geneva, World Health Organization, 1959, pp 857–862.Google Scholar
  101. 101.
    Dutt AK, Alwi S, Velauthan T: A shellfish-borne cholera outbreak in Malaysia. Trans R Soc Trop Med Hyg 65: 815–818, 1971.PubMedGoogle Scholar
  102. 102.
    Cohen J, Schwartz T, Klasmer R, et al: Epidemiological aspects of cholera El Tor outbreak in a non-endemic area. Lancet ii: 86–89, 1971.Google Scholar
  103. 103.
    Sutton RGA: An outbreak of cholera in Australia due to food served in flight on an international aircraft. J Hyg 72: 441–451, 1974.PubMedGoogle Scholar
  104. 104.
    Merson MH, Martin WT, Craig JP, et al: Cholera on Guam, 1974: Epidemiologie findings and isolation of non-toxinogenic strains. Am J Epidmiol 105: 349–361, 1977.Google Scholar
  105. 105.
    Mclntrye RC, Tira T, Flood T, et al: Modes of transmission of cholera in a newly infected population on an atoll: implications for control measures. Lancet i: 311–314, 1979.Google Scholar
  106. 106.
    Kuberski T, Flood T, Tera T, et al: Cholera in the Gilbert Islands. I. Epidemiological features. Am J Trop Med Hyg 28: 677–684, 1979.PubMedGoogle Scholar
  107. 107.
    Goh KT, Lam S, Kumarapathy S, et al: A common source foodborne outbreak of cholera in Singapore. Int J Epidemiol 13: 210–215, 1984.PubMedGoogle Scholar
  108. 108.
    Holmberg SD, Harris JR, Kay DE, et al: Foodborne transmission of cholera in Micronesian households. Lancet i: 325–327, 1984.Google Scholar
  109. 109.
    Gunn RA, Kimball AM, Pollard RA, et al: Bottle feeding as a risk factor for cholera in infants. Lancet ii: 730–732, 1979.Google Scholar
  110. 110.
    Gunn RA, Kimball AM, Mathew PP, et al: Cholera in Bahrain: epidemiological characteristics of an outbreak. Bull WHO 59: 61–66, 1981.PubMedGoogle Scholar
  111. 111.
    Glass RI, Svennerholm A-M, Stoll BJ, et al: Protection against cholera in breast-fed children by antibodies in breast milk. New Engl J Med 308: 1389–1392, 1983.PubMedGoogle Scholar
  112. 112.
    Black RE, Brown KH, Becker S, et al: Contamination of weaning foods and transmission of enterotoxigenic Escherichia coli diarrhoea in children in rural Bangladesh. Trans R Soc Trop Med Hyg 76: 259–264, 1982.PubMedGoogle Scholar
  113. 113.
    Pan American Health Organization: Epidemiol Bull 12: 1–12, 1991.Google Scholar
  114. 114.
    Khan MU, Shahidullah M, Ahmed WU, et al: The El Tor cholera epidemic in Dhaka in 1974 and 1975. Bull WHO 61: 653–659, 1983.PubMedGoogle Scholar
  115. 115.
    Oseasohn RS, Ahmad S, Islan M, et al: Clinical and bacteriological findings among families of cholera patients. Lancet i: 340–342, 1966.Google Scholar
  116. 116.
    Bart KJ, Huq Z, Khan M, et al: Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis 121:S17–S24, 1970.Google Scholar
  117. 117.
    Tamayo JF, Mosley WH, Alvero MG, et al: Studies of cholera El Tor in the Philippines. 3. Transmission of infection among household contacts of cholera patients. Bull WHO 33: 645–649, 1965.PubMedGoogle Scholar
  118. 118.
    Kuberski T: Cholera on Nauru: possible non-point source transmission. Med J Aust 2: 563–566, 1980.PubMedGoogle Scholar
  119. 119.
    Dobin A, Felix H: Du role de la sueur dans l’epidemiologie du cholera en pays sec. Bull Acad Natl Med (Paris) 156: 845–852, 1972.Google Scholar
  120. 120.
    Isaacson M, Clarke KR, Ellacombe GH, et al: The recent cholera outbreak in the South African gold mining industry: A preliminary report. S Afr Med J 48: 2557–2560, 1974.PubMedGoogle Scholar
  121. 121.
    Isaacson M, Smit P: The survival and transmission of V. cholerae in an artificial tropical environment. Prog Water Tech 11: 89–96, 1979.Google Scholar
  122. 122.
    Abrutyn E, Gangarosa E, Forrest J, et al: Cholera in a vaccinated American: Immunological response to vaccination and disease. Ann Intern Med 74: 228–231, 1971.PubMedGoogle Scholar
  123. 123.
    Ryder RW, Mizanur Rahman ASM, Alim ARMA: An outbreak of nosocomial cholera in a rural Bangladesh hospital. J Hosp Inf 8: 275–282, 1986.Google Scholar
  124. 124.
    Pollitzer R: Cholera. Geneva, World Health Organization, 1959, pp 862–863.Google Scholar
  125. 125.
    Pollitzer R: Cholera. Geneva, World Health Organization, 1959, pp 863–865.Google Scholar
  126. 126.
    Gangarosa EJ, Mosley WH: Epidemiology and surveillance of cholera, in Barua D, Burrows W. (eds.): Cholera. Philadelphia, W.B. Saunders, 1974.Google Scholar
  127. 127.
    Barua D, Paguio AS: ABO blood groups and cholera. Ann Human Biol 4: 489–492, 1977.Google Scholar
  128. 128.
    Chandhuri A: Cholera and blood-group. Lancet ii: 404–405, 1977.Google Scholar
  129. 129.
    Levine MM, Nalin DR, Renneis MB, et al: Genetic susceptibility to cholera. Ann Hum Biol 6: 369–374, 1979.PubMedGoogle Scholar
  130. 130.
    Glass RI, Holmgren J, Haley CE, et al: Predisposition for cholera of individuals with O blood group: possible evolutionary significance. Am J Epidemiol 121: 791–796, 1985.PubMedGoogle Scholar
  131. 131.
    Glass RI, Stoll BJ, Wyatt RG, et al: Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Paediatr Scand 75: 713–718, 1986.PubMedGoogle Scholar
  132. 132.
    Rosenberg IH, Greenough WB, Lindenbaum J, Gordon RS: Nutritional studies in cholera, in Proceedings of the Cholera Research Symposium (Jan. 24–29, 1965, Honolulu). PHS Publication No. 1328, Washington, DC, U.S. Government Printing Office.Google Scholar
  133. 133.
    Gangarosa EJ, Beisel WR, Benyajati C, et al: The nature of the gastrointestinal lesion in Asiatic cholera and its relation to pathogenesis. A biopsy study. Am J Trop M 9: 125–135, 1960.PubMedGoogle Scholar
  134. 134.
    Sprinz H, Sribbhibhadh R, Gangarosa EJ, et al: Biopsy of small bowel of Thai people with special reference to recovery from Asiatic cholera and to an internal malabsorption syndrome. Am J Clin Pathol 38: 43–51, 1962.PubMedGoogle Scholar
  135. 135.
    Lindenbaum J, Greenough WB, Islam MR: Antibiotic therapy of cholera in children. Bull WHO 37: 529–538, 1967.PubMedGoogle Scholar
  136. 136.
    Karchner AW, Curlin GT, Huq MI, Hirschhorn N: Furazolidone in pediatric cholera. Bull WHO 43: 373–378, 1970.Google Scholar
  137. 137.
    Palmer DL, Koster AK, Alam MT, and Islam MR: Nutritional status: a determinant of the severity of diarrhea in patients with cholera. J Infect Dis 134: 8–14, 1976.PubMedGoogle Scholar
  138. 138.
    Snyder JD, Blake PA: Is cholera a problem for U.S. travelers? JAMA 247: 2268–2269, 1982.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Roger I. Glass
  • Robert E. Black

There are no affiliations available

Personalised recommendations